🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/08/2004 | 42,70 | 42,89 | 42,31 | 42,55 | -0,45% | 1,36% | 3.043.811 |
| 12/08/2004 | 42,75 | 43,10 | 42,56 | 42,74 | -0,47% | 1,27% | 4.507.553 |
| 11/08/2004 | 42,61 | 43,02 | 42,54 | 42,94 | +0,78% | 1,14% | 5.289.361 |
| 10/08/2004 | 42,27 | 42,61 | 41,91 | 42,61 | +1,32% | 1,65% | 4.132.998 |
| 09/08/2004 | 41,75 | 42,41 | 41,58 | 42,05 | +1,08% | 1,99% | 4.812.102 |
| 06/08/2004 | 41,98 | 42,18 | 41,47 | 41,60 | -1,87% | 1,68% | 6.396.992 |
| 05/08/2004 | 42,74 | 42,89 | 42,22 | 42,40 | -1,05% | 1,56% | 4.706.987 |
| 04/08/2004 | 42,86 | 43,10 | 42,61 | 42,84 | +0,07% | 1,16% | 4.610.362 |
| 03/08/2004 | 43,15 | 43,35 | 42,80 | 42,81 | -1,32% | 1,28% | 5.477.477 |
| 02/08/2004 | 43,23 | 43,61 | 43,04 | 43,39 | +0,26% | 1,30% | 4.690.848 |
| 30/07/2004 | 43,08 | 43,61 | 42,86 | 43,27 | -0,11% | 1,73% | 4.230.252 |
| 29/07/2004 | 42,97 | 43,70 | 42,72 | 43,32 | +0,84% | 2,29% | 5.559.954 |
| 28/07/2004 | 43,03 | 43,05 | 42,35 | 42,96 | -0,04% | 1,64% | 5.822.688 |
| 27/07/2004 | 42,98 | 43,00 | 42,54 | 42,98 | +0,09% | 1,07% | 5.450.962 |
| 26/07/2004 | 43,09 | 43,32 | 42,48 | 42,94 | -0,35% | 1,95% | 6.477.374 |
| 23/07/2004 | 43,23 | 43,50 | 42,60 | 43,09 | -0,44% | 2,10% | 5.767.878 |
| 22/07/2004 | 42,74 | 43,46 | 42,65 | 43,28 | +1,73% | 1,90% | 7.717.158 |
| 21/07/2004 | 43,18 | 43,70 | 42,55 | 42,55 | -0,54% | 2,67% | 7.868.803 |
| 20/07/2004 | 42,46 | 42,92 | 42,29 | 42,78 | +0,85% | 1,48% | 7.977.271 |
| 19/07/2004 | 42,75 | 42,88 | 42,27 | 42,41 | -0,78% | 1,43% | 5.755.511 |
| 16/07/2004 | 42,89 | 42,94 | 42,22 | 42,75 | +0,20% | 1,67% | 6.832.017 |
| 15/07/2004 | 43,53 | 43,79 | 42,65 | 42,66 | -2,12% | 2,61% | 5.740.001 |
| 14/07/2004 | 43,46 | 43,99 | 43,46 | 43,59 | +0,29% | 1,21% | 5.390.807 |
| 13/07/2004 | 43,60 | 43,65 | 43,27 | 43,46 | -0,26% | 0,88% | 3.820.274 |
| 12/07/2004 | 43,76 | 43,85 | 43,23 | 43,58 | -0,41% | 1,42% | 4.658.779 |
| 09/07/2004 | 43,94 | 44,15 | 43,65 | 43,76 | -0,13% | 1,15% | 4.315.035 |
| 08/07/2004 | 43,75 | 44,64 | 43,75 | 43,82 | -0,84% | 2,03% | 6.199.444 |
| 07/07/2004 | 44,38 | 44,54 | 43,98 | 44,19 | -0,62% | 1,27% | 4.955.154 |
| 06/07/2004 | 44,71 | 44,90 | 44,43 | 44,47 | -0,55% | 1,05% | 4.311.053 |
| 02/07/2004 | 45,13 | 45,19 | 44,68 | 44,71 | -0,40% | 1,14% | 3.377.494 |